Lincoln National Corp’s Allergan plc AGN Stock Holding History

Lincoln National Corp’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,380	Closed	-$264K	–	691
2019 Q4	$264K	Buy	+1,380	New	+$249K	0.01%	528
2018 Q1	–	Sell	-2,074	Closed	-$340K	–	650
2017 Q4	$340K	Buy	+2,074	New	+$372K	0.01%	458
2017 Q3	–	Sell	-1,031	Closed	-$251K	–	415
2017 Q2	$251K	Buy	1,031 +36	+4%	+$8.46K	0.01%	298
2017 Q1	$237K	Buy	+995	New	+$232K	0.01%	287
2016 Q4	–	Sell	-874	Closed	-$201K	–	325
2016 Q3	$201K	Buy	+874	New	+$214K	0.01%	274

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lincoln National Corp's AGN Position: Q1 2020 in Review

Lincoln National Corp sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,380 shares — an estimated $264K sold.

Lincoln National Corp first reported a position in AGN in Q3 2016 and held it in 5 quarters. The position peaked at $340K in Q4 2017. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

Lincoln National Corp reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
Lincoln National Corp sold 1,380 Allergan plc shares in Q1 2020, an estimated $264K.
Lincoln National Corp first reported a position in Allergan plc in Q3 2016 and held it in 5 quarters.
Lincoln National Corp's Allergan plc position peaked at $340K in Q4 2017.
876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Lincoln National Corp's 13F filing for Q1 2020, filed 24 Apr 2020.